IPO - Jasper Therapeutics, Inc.

Form Type: CORRESP

Filing Date: 2025-03-24

Corporate Action: Ipo

Type: New

Accession Number: 000101376225001604

Filing Summary: Jasper Therapeutics, Inc. has filed a request to accelerate the effectiveness of its Registration Statement on Form S-3, which was filed on March 19, 2025. The company seeks to have the registration become effective at 4:30 p.m. Eastern Time on March 26, 2025, or as soon as possible thereafter. The company acknowledges its responsibilities under both the Securities Act of 1933 and the Securities Exchange Act of 1934 concerning the proposed offering of securities as specified in the Registration Statement. Furthermore, the company has authorized its outside counsel to modify or withdraw this request if necessary.